Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Business Research Company | PRODUCT CODE: 1559149

Cover Image

PUBLISHER: The Business Research Company | PRODUCT CODE: 1559149

Duodenal Ulcer Treatment Global Market Report 2024

PUBLISHED:
PAGES: 175 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 5000
PDF (Site License)
USD 7500
PDF (Enterprise License)
USD 10000

Add to Cart

Duodenal ulcer treatment encompasses the methods used to heal and manage ulcers located in the duodenum, the initial segment of the small intestine. This treatment typically includes a mix of medications aimed at decreasing acid production and fostering healing, lifestyle modifications, and occasionally, treatments to eliminate Helicobacter pylori bacteria, which is a frequent cause of duodenal ulcers.

The primary treatment options for duodenal ulcers are antibiotics, proton pump inhibitors, antacids, potassium-competitive acid blockers, H2-antagonists, ulcer-protective drugs, and surgery. Antacids are specifically used to address bacterial infections such as those caused by Helicobacter pylori, which can contribute to the development of duodenal ulcers. This aids in eradicating the bacterial infection and facilitating proper ulcer healing. These treatments are applicable to both adults and the elderly, and are distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

The duodenal ulcer treatment market research report is one of a series of new reports from The Business Research Company that provides duodenal ulcer treatment market statistics, including duodenal ulcer treatment industry global market size, regional shares, competitors with a duodenal ulcer treatment market share, detailed duodenal ulcer treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the duodenal ulcer treatment industry. This duodenal ulcer treatment research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The duodenal ulcer treatment market size has grown strongly in recent years. It will grow from $93.42 billion in 2023 to $99.99 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. The increase observed in the past can be linked to several factors, including a rising preference among patients for non-invasive treatments, heightened awareness of gastrointestinal health, a growing number of cigarette smokers, more consumers of alcohol and tobacco, and a greater integration of digital health solutions.

The duodenal ulcer treatment market size is expected to see strong growth in the next few years. It will grow to $133.10 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. The anticipated growth in the forecast period is expected due to a rise in the prevalence of diseases, an expansion of medical infrastructure and healthcare facilities, increased awareness of treatment options, a growing inclination towards minimally invasive procedures, and enhanced government efforts to promote awareness. Key trends to watch for during this period include advancements in technology, the incorporation of probiotics, the use of telemedicine, nutritional therapy, and the integration of evidence-based practices.

The anticipated growth in the duodenal ulcer treatment market is linked to the rising number of cigarette smokers. Cigarette smokers are individuals who regularly consume cigarettes, which are small rolls of paper filled with tobacco that are smoked by inhaling and exhaling the smoke. The rise in cigarette smoking is influenced by cultural factors, public policies, and socioeconomic conditions. Managing duodenal ulcers in smokers requires a thorough approach, including ulcer-specific treatments, smoking cessation programs, lifestyle changes, and continuous monitoring to promote healing and prevent recurrence. For example, data from the Office for National Statistics in the UK revealed that in 2022, approximately 6.4 million adults over 18 were cigarette smokers, representing 12.9% of the population. Additionally, among the 16 to 24 age group, e-cigarette use rose to 15.5% in 2022, up from 11.1% in 2021. This increase in smoking rates is contributing to the expansion of the duodenal ulcer treatment market.

Key players in the duodenal ulcer treatment market are concentrating on creating advanced products, such as combination kits for treating both duodenal ulcers and H. pylori infections, to improve ulcer healing. A combination kit generally involves a therapy that includes medications designed to heal the ulcer and eliminate the H. pylori bacteria. For example, in April 2023, Akums Drugs and Pharmaceutical Limited, an Indian pharmaceutical company, introduced an innovative combination kit for duodenal ulcers related to H. pylori infection. This kit combines three effective medications-amoxicillin, clarithromycin, and esomeprazole-to combat H. pylori bacteria and decrease gastric acid production, addressing the main causes of duodenal ulcers. The Central Drugs Standard Control Organization (CDSCO) has approved this kit for treating duodenal ulcers and eliminating H. pylori in patients with active or healed peptic ulcers.

In June 2022, Glenmark Pharmaceuticals Ltd., an Indian company specializing in duodenal ulcer treatments, acquired over-the-counter (OTC) drug products from Wockhardt Limited for an undisclosed sum. This acquisition highlights Glenmark's ongoing efforts to expand in the US OTC market and demonstrates its dedication to providing affordable, high-quality medications. Wockhardt Limited, also based in India, is a pharmaceutical and biotechnology company that offers treatments for duodenal ulcers.

Major companies operating in the duodenal ulcer treatment market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A, Bristol-Myers Squibb, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sandoz AG, Sun Pharmaceutical Industries Limited, Eisai Co. Ltd., Aurobindo Pharma Limited, Cipla Inc., Dr. Reddy's Laboratories Limited, Intas Pharmaceuticals Limited, Apotex Inc., Lupin Limited, Glenmark Pharmaceuticals Limited, Alkem Laboratories Limited, Jubilant Pharma Limited, Torrent Pharmaceuticals Limited

North America was the largest region in the duodenal ulcer treatment market in 2023. The regions covered in the duodenal ulcer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the duodenal ulcer treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The duodenal ulcer treatment market consists of revenues earned by entities by providing services such as endoscopic therapies, follow-up care, and lifestyle and dietary changes. The market value includes the value of related goods sold by the service provider or included within the service offering. The duodenal ulcer treatment market also includes sales of endoscopic devices, surgical instruments, H2-receptor antagonists, and diagnostic tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Duodenal Ulcer Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on duodenal ulcer treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for duodenal ulcer treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The duodenal ulcer treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Antibiotics; Proton Pump Inhibitors; Antacids; Potassium-Competitive Acid Blockers; H2-Antagonist; Ulcer Protective Drugs; Surgery
  • 2) By Application: Adult; Elderly
  • 3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
  • Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Bayer AG; Sanofi S.A; Bristol-Myers Squibb
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.
Product Code: r19653

Table of Contents

1. Executive Summary

2. Duodenal Ulcer Treatment Market Characteristics

3. Duodenal Ulcer Treatment Market Trends And Strategies

4. Duodenal Ulcer Treatment Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Duodenal Ulcer Treatment Market Size and Growth

  • 5.1. Global Duodenal Ulcer Treatment Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Duodenal Ulcer Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Duodenal Ulcer Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Duodenal Ulcer Treatment Market Segmentation

  • 6.1. Global Duodenal Ulcer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Antibiotics
  • Proton Pump Inhibitors
  • Antacids
  • Potassium-Competitive Acid Blockers
  • H2-Antagonist
  • Ulcer Protective Drugs
  • Surgery
  • 6.2. Global Duodenal Ulcer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Adult
  • Elderly
  • 6.3. Global Duodenal Ulcer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

7. Duodenal Ulcer Treatment Market Regional And Country Analysis

  • 7.1. Global Duodenal Ulcer Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Duodenal Ulcer Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Duodenal Ulcer Treatment Market

  • 8.1. Asia-Pacific Duodenal Ulcer Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Duodenal Ulcer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Duodenal Ulcer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Duodenal Ulcer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Duodenal Ulcer Treatment Market

  • 9.1. China Duodenal Ulcer Treatment Market Overview
  • 9.2. China Duodenal Ulcer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Duodenal Ulcer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Duodenal Ulcer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Duodenal Ulcer Treatment Market

  • 10.1. India Duodenal Ulcer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Duodenal Ulcer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Duodenal Ulcer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Duodenal Ulcer Treatment Market

  • 11.1. Japan Duodenal Ulcer Treatment Market Overview
  • 11.2. Japan Duodenal Ulcer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Duodenal Ulcer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Duodenal Ulcer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Duodenal Ulcer Treatment Market

  • 12.1. Australia Duodenal Ulcer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Duodenal Ulcer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Duodenal Ulcer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Duodenal Ulcer Treatment Market

  • 13.1. Indonesia Duodenal Ulcer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Duodenal Ulcer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Duodenal Ulcer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Duodenal Ulcer Treatment Market

  • 14.1. South Korea Duodenal Ulcer Treatment Market Overview
  • 14.2. South Korea Duodenal Ulcer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Duodenal Ulcer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Duodenal Ulcer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Duodenal Ulcer Treatment Market

  • 15.1. Western Europe Duodenal Ulcer Treatment Market Overview
  • 15.2. Western Europe Duodenal Ulcer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Duodenal Ulcer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Duodenal Ulcer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Duodenal Ulcer Treatment Market

  • 16.1. UK Duodenal Ulcer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Duodenal Ulcer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Duodenal Ulcer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Duodenal Ulcer Treatment Market

  • 17.1. Germany Duodenal Ulcer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Duodenal Ulcer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Duodenal Ulcer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Duodenal Ulcer Treatment Market

  • 18.1. France Duodenal Ulcer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Duodenal Ulcer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Duodenal Ulcer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Duodenal Ulcer Treatment Market

  • 19.1. Italy Duodenal Ulcer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Duodenal Ulcer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Duodenal Ulcer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Duodenal Ulcer Treatment Market

  • 20.1. Spain Duodenal Ulcer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Duodenal Ulcer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Duodenal Ulcer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Duodenal Ulcer Treatment Market

  • 21.1. Eastern Europe Duodenal Ulcer Treatment Market Overview
  • 21.2. Eastern Europe Duodenal Ulcer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Duodenal Ulcer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Duodenal Ulcer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Duodenal Ulcer Treatment Market

  • 22.1. Russia Duodenal Ulcer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Duodenal Ulcer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Duodenal Ulcer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Duodenal Ulcer Treatment Market

  • 23.1. North America Duodenal Ulcer Treatment Market Overview
  • 23.2. North America Duodenal Ulcer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Duodenal Ulcer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Duodenal Ulcer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Duodenal Ulcer Treatment Market

  • 24.1. USA Duodenal Ulcer Treatment Market Overview
  • 24.2. USA Duodenal Ulcer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Duodenal Ulcer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Duodenal Ulcer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Duodenal Ulcer Treatment Market

  • 25.1. Canada Duodenal Ulcer Treatment Market Overview
  • 25.2. Canada Duodenal Ulcer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Duodenal Ulcer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Duodenal Ulcer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Duodenal Ulcer Treatment Market

  • 26.1. South America Duodenal Ulcer Treatment Market Overview
  • 26.2. South America Duodenal Ulcer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Duodenal Ulcer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Duodenal Ulcer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Duodenal Ulcer Treatment Market

  • 27.1. Brazil Duodenal Ulcer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Duodenal Ulcer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Duodenal Ulcer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Duodenal Ulcer Treatment Market

  • 28.1. Middle East Duodenal Ulcer Treatment Market Overview
  • 28.2. Middle East Duodenal Ulcer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Duodenal Ulcer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Duodenal Ulcer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Duodenal Ulcer Treatment Market

  • 29.1. Africa Duodenal Ulcer Treatment Market Overview
  • 29.2. Africa Duodenal Ulcer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Duodenal Ulcer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Duodenal Ulcer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Duodenal Ulcer Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Duodenal Ulcer Treatment Market Competitive Landscape
  • 30.2. Duodenal Ulcer Treatment Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Merck & Co. Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Bayer AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Sanofi S.A
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Bristol-Myers Squibb
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Duodenal Ulcer Treatment Market Other Major And Innovative Companies

  • 31.1. AstraZeneca plc
  • 31.2. Abbott Laboratories
  • 31.3. GlaxoSmithKline plc
  • 31.4. Takeda Pharmaceutical Company Limited
  • 31.5. Teva Pharmaceutical Industries Ltd.
  • 31.6. Mylan N.V.
  • 31.7. Sandoz AG
  • 31.8. Sun Pharmaceutical Industries Limited
  • 31.9. Eisai Co. Ltd.
  • 31.10. Aurobindo Pharma Limited
  • 31.11. Cipla Inc.
  • 31.12. Dr. Reddy's Laboratories Limited
  • 31.13. Intas Pharmaceuticals Limited
  • 31.14. Apotex Inc.
  • 31.15. Lupin Limited

32. Global Duodenal Ulcer Treatment Market Competitive Benchmarking

33. Global Duodenal Ulcer Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Duodenal Ulcer Treatment Market

35. Duodenal Ulcer Treatment Market Future Outlook and Potential Analysis

  • 35.1 Duodenal Ulcer Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Duodenal Ulcer Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Duodenal Ulcer Treatment Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!